Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T19:06:04.268Z.
Calculation as of: 2026-10-06T19:06:04.268Z.
Quote observation: 2026-10-06T19:05:23.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: cf0630fc9642b75147419b140bafddb7ccff0a2362c2d95f2dd7172ee2000ae5
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
Market Cap
$931.97M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$937.88M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$912.83M
EV/EBIT Ratio
34.11x
TTM Avg
30.80x
3Y Avg
40.41x
5Y Avg
53.37x
Market Cap
$980.03M
EV/EBIT Ratio
64.31x
TTM Avg
51.40x
3Y Avg
38.19x
5Y Avg
39.85x
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CeriBell, Inc. (CBLL) | $931.94M | N/A | N/A | N/A | N/A |
| Seaport Therapeutics, Inc. Common Stock (SPTX)vs › | $931.97M | N/A | N/A | N/A | N/A |
| MoonLake Immunotherapeutics (MLTX)vs › | $937.88M | N/A | N/A | N/A | N/A |
| Kura Oncology, Inc. (KURA)vs › | $938.65M | N/A | N/A | N/A | N/A |
| HealthStream, Inc. (HSTM)vs › | $912.83M | 34.11x | 30.80x | 40.41x | 53.37x |
| Savara Inc. (SVRA)vs › | $956.87M | N/A | N/A | N/A | N/A |
| Bioventus Inc. (BVS)vs › | $899.44M | 18.34x | 17.93x | 24.19x | 30.14x |
| Aktis Oncology, Inc. (AKTS)vs › | $962.35M | N/A | N/A | N/A | N/A |
| Pacira BioSciences, Inc. (PCRX)vs › | $980.03M | 64.31x | 51.40x | 38.19x | 39.85x |
| Arbutus Biopharma Corp (ABUS)vs › | $883.98M | 5.90x | 5.93x | 5.93x | 5.93x |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
